POINT-OF-CARE (POC) DIAGNOSTICS FOR ANTIMICROBIAL RESISTANT PATHOGENS
$300,000N01FY2022AINIH
Zymeron Corporation, Durham NC
Investigators
Abstract
To develop diagnostics for antimicrobial resistant pathogens.
View original record on NIH RePORTER →Zymeron Corporation, Durham NC
To develop diagnostics for antimicrobial resistant pathogens.
View original record on NIH RePORTER →